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Summary: We compared a Spectrophotometric screening test measuring faecal porphyrin concentration with an
HPLC method. There was a good overall correlation between both methods although some scatter was observed.
ROC plot analysis of the screening test leads to a cut-off value of 35 nmol porphyrin per g faeces, wet weight with
a sensitivity of 97% and a specificity of 96%. These results indicate that the screening test is quite useful for
detection of increased total faecal porphyrin concentration, but less useful in accurate measurement of increased
total faecal porphyrin concentration.
Introduction
Recently we compared a first-line Spectrophotometric
screening test for urine porphyrins with a high-perfor-
mance liquid Chromatographie (HPLC) method for
quantitative measurement of porphyrins. The screening
test proved to be reliable. Sensitivity and specificity
were 96% and 86%, respectively (1). Porphyrin concen-
trations in urine specimens with a positive screening test
are quantified using an HPLC method. With this method
the individual porphyrin fractions can be investigated,
which is necessary for identification of the kind of por-
phyria. To correctly identify the kind of porphyria, ex-
amination of faecal porphyrins is sometimes also re-
quired (2-5). This is the case of establishing the diagno-
sis of erythropoietic protoporjphyria, variegate porphyria
and hereditary coproporphyria; then faecal porphyrins
must also be differentiated by using the HPLC method.
Quantitative determination of faecal porphyrins and
urine porphyrins are equally time consuming. Therefore
a reliable screening test for faecal porphyrins would also
be quite useful. Several methods have been criticized
(2) but the method published by Lockwood et al. (6)
is supposed to be useful because interference of faecal
chlorophyll and carotenoid pigments is excluded (6, 7).
This method has been criticized by Pudek et al. (7) be-
cause measurement of the Soret band in extracts of nor-
mal stool specimens would be inaccurate. However, our
preliminary results were encouraging. The method has
been shown by others to perform well (3) but has not
yet been compared with an HPLC method.
We used the screening procedure of Lockwood et al. (6)
for extraction and measurement of faecal porphyrins fol-
lowed by measurement with an HPLC method as has
been described (8). We compared the sum of all faecal
porphyrins (HPLC) with the results of the quantitative
screening test.
Materials and Methods
Screening test for increased faecal porphyrin
concentration
Quantitative measurement of faecal porphyrin concentration is per-
formed as described by Lochvood et al. (6) and expressed per g
wet weight: 25-50 mg faeces is collected and mixed (vortex) with
1 ml cone. HC1 (1.18 kg/1) until a homogenous suspension is ob-
tained. After 5 minutes the suspension is mixed and 3 ml diethyl
ether is added. The suspension with the ether is thoroughly mixed
until a homogenous emulsion is obtained. Then 3 ml distilled water
is added (within 10 minutes after mixing the faeces with the HC1).
The emulsion is centrifuged at 2500 g for 10 minutes.
Eur J Clin Chem Clin Biochem 1995; 33 (No 5)
286 Zuijderhoudt et al.: Screening for increased faecal poφhyrin
From the lower aqueous layer approximately 3 ml is transferred to
a recording spectrophotometer cuvette and scanned from 390 to
425 nm. Peak height is measured as the difference between the top
of the peak and a tangent to the baseline curve drawn between two
suitable points on each side of the porphyrin peak (e.g. 390 and
425 nm) (6). The peak height (in units of absorbance) is multiplied
by 14.850, and divided by the weight in mg resulting in nmol por-
phyrin per g faeces (wet weight). The coefficient of variation of
the method is 1% (n = 25), at the level of 65 nmol/g faeces.
Quanti tat ive measurement of total faecal porphyrin
concentration with HPLC
Our materials and procedures are in essence the same as those
described extensively by Beukeveld et al. (8). In summary: we used
a Biocompatible Binary LC Pump model 250 (Perkin Elmer Corp.,
Norvvalk CT, USA). Samples were injected in a Rheodyne injector
(Rheodyne Inc. Cotati CA, USA) with a 200 μΐ loop. Separation
was performed on a 20 cm column (5 μιη particles RP18, Brownlee
Labs Inc., Santa Clara, CA, USA) preceded by a guard column
filled with the same material. Separation of the porphyrins with a
solvent gradient was performed exactly as described (8). The
solvent gradient started with a low concentration of dimethylpyri-
dine-phosphoric acid and ended with a high concentration of meth-
anol both in an acetonitrile-acetone-water mixture.
Spectrofluorometric detection of the porphyrins was performed
with a LS-5 spectrofluorometer (Perkin Elmer Corp., Norwalk, CT,
USA): λ excitation was 407 nm, λ emission was 620 nm with band
widths of 10 and 20 nm respectively.
Reagents, eluents and stock standard solution of porphyrins have
been described (8). Stock internal standard solution and working
standards were the same as described. The coefficient of variation
of the method is 6% (n = 25).
Specimens
Samples were fresh or stored at -25 °C and protected from light
by aluminum foil. Samples were processed and measurements were
performed as soon as possible.
Dry weight — wet weight ratio of faeces
To facilitate comparison with the literature, we measured the dry
weight ratio of 94 specimens by drying until weight remained con-
stant. The mean ratio was 0.25 and the standard deviation was 0.06.
Patients
We only used specimens from patients suspected of having por-
phyria (n = 164). The faecal porphyrin concentration as measured
by HPLC was not increased in 100 patients. Clinical diagnosis
in the remaining 64 patients was: porphyria cutanea tarda, n = 7;
variegate porphyria, n = 9; acute intermittent porphyria; n = 1;
erythropoietic protoporphyria, n = 1; hereditary coproporphyria,
n = 33; none, n = 13.
Reference value
In 58 healthy persons aged 5 to 65 years (mean value 30 years)
total faecal porphyrin concentration was calculated using the sum
of copro-1-, copro-3-, deutero-, pempto-, meso- and protoporphyrin
values as measured by HPLC:
Faecal porphyrin concentration higher than 45 nmol/g was consid-
ered increased. The mean concentration was 21 nmol/g; SD = 12
nmol/g; the range of the measured values was 5-49 nmol/g.
Statistical methods
A receiver-operating characteristic (ROC) graph was calculated
and constructed as described (9), although we refer to the x-axis
as "false positive fraction". The area under the graph is estimated
by weighing. Linear regression analysis is performed by the least
squares method.
Results
Relation between the screening method and
the HPLC method: no increase in faecal
porphyrin concentration (HPLC method)
Figure 1 shows the relation between the screening test
and the HPLC method. Several patients with clinical di-
agnosis porphyria cutanea tarda did not have an
increased faecal total porphyrin concentration. The same
applies to a patient with variegate porphyria. Though
there is some scatter of the results, a correlation between
both methods is clear. Regression analysis revealed:
y = 0.95x -1, y = screening test, χ = HPLC method;
r = 0.79.
Relation between the screening method and
the HPLC method: increased faecal porphyrin
concentration (HPLC method)
Figure 2A illustrates a wide scatter of values. Visual
inspection suggests that divergent regression curves can
be calculated from the values of patients with hereditary
coproporphyria and from the values measured in faeces
of patients with variegate porphyria, porphyria cutanea
tarda and erythropoietic protoporphyria.
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Fig. 1 Faecal porphyrin concentration: relation between the
screening test and the HPLC method. Scattergram of faecal por-
phyrin concentration from patients suspected of porphyria without
increased excretion, as measured by HPLC (^ 45 nmol/g).
• porphyria cutanea tarda; τ variegate porphyria; · no diagnosis;
ή = 100.
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Fig. 2a, b Faecal porphyrin concentration: relation between the
screening test and the HPLC method.
a: Scattergram of faecal porphyrin concentration from all patients
suspected of porphyria with increased concentration from 45 up to
500 nmol/g, as measured by HPLC; n = 51.
b: Scattergram of faecal porphyrin concentration from all patients
suspected of porphyria with increased concentration from 45 up to
5000 nmol/g, as measured by HPLC; n = 64.
a and b: α porphyria cutanea tarda; τ variegate porphyria; ο hered-
itary coproporphyria; A acute intermittent porphyria; χ erythropoi-
etic protoporphyria; ^  no diagnosis.
the screening method). All values measured by HPLC
> 45 nmol/g are increased porphyrin concentrations.
The area under the ROC curve as measured by weighing
is estimated to be more than 0.98.
Discussion
The screening procedure for faecal porphyrins as de-
scribed by Lockwood et al. (6) is quite similar to the
method for porphyrins in the urine examined by us (1)
and by others (3) previously. The main difference is ex-
traction of caroteno'ids and chlorophyll from the faecal
suspension prior to spectrophotometry of the acid layer.
The screening method of Lockwood et al. (6) seems to
perform quite well (3) and it was convenient for us to
investigate this method.
For evaluation of the screening method, a quantitative
HPLC procedure is necessary. We used the HPLC
method of Beukeveld et al. (8) and measured reference
values for total faecal porphyrins in our own laboratory.
Our range was 5—49 nmol/g wet weight (x = 21
nmol/g, SD = 12 nmol/g) which hardly differed from
the range published by Beukeveld et al. (8): 2—57
nmol/g wet weight. The upper limit of our reference in-
terval is 45 nmol/g. Often faecal porphyrin concentra-
tions are expressed per g dry weight. It has been shown
that values per g wet weight have the same diagnostic
value provided of course that reference values are ex-
pressed in the same way (10). In that paper the percen-
tage dry weight to wet weight was 25.8% (SD = 8.5%,
n = 213). This mean value is the same as our value (see
section Materials and Methods). Therefore we can com-
pare our reference value with those who expressed it per
Regression analysis of all values revealed:
y = 0.49x +61, y = screening test, χ = HPLC
method; r = 0.48.
Figure 2b does not illustrate a wide scatter of values.
The values depicted in figure 2a are incorporated in fig-
ure 2b.
Regression analysis revealed:
y = 0.50 χ + 65, y = screening test, χ = HPLC
method; r - 0.94.
Receiver-operating characteristic (ROC) plot
From all 164 pairs of values, a ROC plot was con-
structed. In figure 3 the false positive and true positive
values are illustrated from seven decision threshold val-
ues ranging from 15 to 65 nmol/g (as measured using
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Fig. 3 ROC plot of the number of samples measured with the
screening test showing normal and increased faecal porphyrin con-
centration as compared to the number of samples selected with the
HPLC method (n = 164). Values in the graph indicate the cut-off
values for increased faecal porphyrin concentration in nmol/g as
measured with the screening test. The cut-off value in the HPLC
method is 45 nmol/g.
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g dry weight. The reference value < 200 nmol/g dry
weight found by others (2, 3, 6, 11) is almost identical
to our value: ^  45 nmol/g wet weight (which is approxi-
mately 180 nmol/g dry weight). Therefore our compari-
son of the screening method with our HPLC method
possibly applies to other methods as well.
In figure 1 some scatter of values is apparent. However,
there is a clear correlation between both methods. Con-
trary to our results with the screening method for por-
phyrins in urine (1), this method for faecal extracts al-
ways measures a porphyrin concentration if a concentra-
tion higher than 5 nmol/g wet weight is found by HPLC.
In several cases the faecal extract of known patients with
porphyria cutanea tarda did not show increased porphy-
rin concentration. These faecal samples may have been
collected from patients in a period of clinical remission
(2). The same holds for the case of variegate porphyria
(4).
In figure 2a/b all patients with increased faecal porphy-
rin concentration are shown. In figure 2b the relation
between both methods is not very different from the one
calculated in figure 2a. However, visual inspection of
figure 2a reveals a wide scatter of values. Patients with
variegate porphyria, porphyria cutanea tarda and one pa-
tient with erythropoietic protoporphyria tend to show a
different regression than patients with hereditary copro-
porphyria. Absorbance at the same concentration of por-
phyrins as measured by HPLC for specimens from the
latter group of patients seemed less than for the other
groups of patients.
Patients with hereditary coproporphyria excrete rela-
tively more coproporphyrins in faeces whereas the other
groups of patients excrete relatively more protoporphy-
rin and protoporphyrin derived porphyrins (2,4).
We wondered whether the ratio of copro- and protopor-
phyrin in these fractions influenced the absorbänce in
the Soret band producing the results shown in figure 2a.
If the molar absorbänce of coproporphyrin in the faecal
extract is less than that for protoporphyriri then some
explanation exists for our observation. However the mo-
lar absorption coefficients published by Lockwood et al.
(6) did not confirm this. We have no explanation for the
scatter of the values in figure 2a. The correlation of our
reference values (HPLC method) with those from litera-
ture suggests that the HPLC method is reasonably accu-
rate; precision is satisfactory too, coefficients of varia-
tion of the HPLC method and the screening method are
respectively 6% and 1%. The sensitivity and specificity
of the screening test (97% and 96%, respectively) are
very good at a cut-off value of 35 nmol/g (fig. 3). There-
fore we chose 35 nmol/g as the upper reference value of
the screening test. In figure 1 some values that were
increased as measured by the screening test will succes-
sively be classified as normal with the HPLC method.
The area under the ROC plot is high, 0.98, illustrating
that this screening test for increased faecal porphyrin
concentration is also quite useful and even superior to
the comparable screening test for increased urine por-
phyrin excretion (1). The method can not be used for
accurate measurement of increased total faecal porphy-
rin concentration.
Acknowledgements
The authors thank Mr. W. Kluitenberg for statistical calculations
and Mrs. Rook for assistance in preparing the manuscript.
References
1. Zuijderhoudt FMJ, Dorresteijn-de Bok J, te Velde K. Evalua-
tion of a first-line spectrophotometric screening test for
increased urine porphyrin excretion. Ann Ciin Biochem
1995; 32:186-9.
2. Elder GH, Smith SO, Jane Smyth S. Laboratory investigation
of the porphyrias. Ann Clin Biochem 1990; 27:395-412.
3. Deacon AC. Performance of screening tests for porphyria. Ann
Clin Biochem 1988; 25:392-7.
4. Hindmarsh JP. The porphyrias: recent advances. Clin Chem
1986; 32:1255-63.
5. Kushner JP. Laboratory diagnosis of the porphyrias. New Eng
J Med 1991; 324:1432-4.
6. Lockwood WH, Poulos V, Rossi E, Curnow DH. Rapid pro-
cedure for fecal prophyrin assay. Clin Chem 1985; 31:1163-7.
7. Pudek MR, Schreiber WE, Jamani A. Quantative fluorometric
screening test for fecal porphyrins. Clin Chem 1991·
37:826-31.
8. Beukeveld GJJ, Wolthers BG, van Saene JJM, de Haan THIJ,
de Ruyter-Buitenhuis LW, van Saene RHF. Patterns of porphy-
rin excretion in feces as determined by liquid chromatography;
reference values and the effect of flora suppression. Clin Chem
1987; 33:2164-70.
9. Zweig , Campbell G. Receiver-operating characteristic
(ROC) plots: a fundamental evaluation tool in clinical medi-
cine. Clin Chem 1993; 39:561-77.
10. Deacon AC. Fecal porphyrin screening. Clin Chem 1990;
36:1383.
11. Blake D, McManus J, Cronin V, Ratnaike S. Fecal copropor*
phyrin isomers in hereditary coproporphyria. Clin Chem 1992;
38:96-100.
Dr. F. M. J. Zuijderhoudt
Deventer Ziekenhuis
Postbus 5001
NL-7400 GC Deventer
The Netherlands
Eur J Clin Chem Clin Biochem 1995; 33 (No 5)
